Συντονιστές
Baxevanis C. N.
Umansky V.
Add to agenda

Presentations

CAR- and TCR-based therapy in solid cancers
Mark as live Clear stage
The power of novel allogeneic CAR-T cell to treat malignant disorders
Mark as live Clear stage
Tolerogenic onco-fetal proteins as emerging targets for novel therapies
Mark as live Clear stage

Speaker